Nyrada Chair John Moore Lifts Stake Above 5% After Acquiring 5 Million Shares
NYR: $0.450 -2.17% · MC: $133M
Nyrada chair John Moore acquired 5 million CDIs off-market, increasing his holding from about 9.5 million to about 14.5 million and making him a substantial holder with 5.58% voting power. Separately, Nyrada reported five patients dosed in its PROTECT-MI trial, up from three at its previous update, with final dosing still targeted for mid-2027.

Comments